UV Infection Control Devices Market Overview:
The global UV infection control devices market size was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.
The UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. As health care-associated infections (HAIs) is on the rise every year, which are caused by microorganisms such as fungi, bacteria, viruses, and parasites that can seriously affect the patients. The UV infection control device works based on UV light that reflects off walls and other surfaces and is absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.
The key factors that drive the growth of the UV infection control devices market include increase in government focus on infection control programs. For instance, the American Hospital Association published "Infection Control in the Hospital," the first and only standards available for many years. In 2015 more than 50% of US hospitals had a version of an infection control program. In 1972, the Hospital Infections Branch at the CDC was formed, and the Association for Practitioners in Infection Control was organized. Furthermore, rise in prevalence of hospital acquired infections (HAI). In addition, rising adoption of technologically advanced UV equipment further supplement the growth of the market. However, high cost of UV infection control devices and stringent government regulations hinder the growth of the market globally. On the contrary, high growth prospects in emerging markets can provide newer opportunities for the UV infection control devices market growth.
UV Infection Control Devices Market Segmentation
The global UV infection control devices market is segmented on the basis of type, end user, and region. By type, the market is classified into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Segment Review
By type, the market is classified into mobile, stationary, and other types. The mobile segment dominated in 2018 and is expected to continue to maintain the lead over the forecast period. This is attributed to its mobility; as the device is light and can be moved to different settings. In addition, the cost of mobile UV infection control devices is less expensive than the stationary IV infection control devices. Furthermore, various benefits offered by these devices also contribute to the growth of the market. For instance, these devices eradicate the infectious diseases by killing them whereas other disinfecting agents act by inhibiting the growth of infectious diseases. Furthermore, these mobile units are specifically designed for the ease of use and elimination of human error. For instance, mobile UV infection devices are available with casters or with a handcarts for maximum mobility. Therefore, the factors aforementioned contribute to the growth of the market.
By Product
Immunodiagnostics segment is projected as one of the most lucrative segment.
By end user, the market is segmented into hospitals, clinics, and others. The hospital segment occupied the largest share of the UV infection control devices market in 2018 owing to factors such as rise in number of UV infection control devices that are used in the medical devices due to surge in cases of hospital acquired infections. In addition, the surge in number of hospitals worldwide is further supporting the market growth. Hospital segment is also the fastest growing end user segment in the market.
By Application
Dog segment holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.
By region, North America accounted for the major UV infection control devices market share in 2018 and is expected to continue this trend, owing to presence of well-established healthcare infrastructure, higher buying power, and high adoption of advanced medical equipment. In addition, rise in cases of hospital acquired infection (HAIs) is another major factor that boosts the growth of the market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period, which is attributed to highly populated countries, with China being the first and India the second most populated countries. Therefore, the region has the potential to offer a huge patient base, which is expected to boost the growth of the Asia-Pacific UV infection control devices market. Furthermore, the improvements in health standards, surge in disposable incomes, and advancements in technology for the development of new UV infection control devices also contribute to the growth of the market in the region.
The global UV infection control devices market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum market share. These include collaboration, product launch, partnership, and acquisition. Some of the key players operating in the UV infection control devices market are CVS Health Corporation, DocMorris, Express Scripts Holding Company, Giant Eagle Inc., Optum Rx Inc., Rowlands Pharmacy, The Kroger Co., Walgreen Co., Walmart Stores Inc., and Apollo Pharmacy.
By Geography
Asia-Pacific region would exhibit the highest CAGR of 10.3% during 2019-2026.
Key Benefits for Stakeholders:
- The study provides an in-depth analysis of the global UV infection control devices market, with current trends and future estimations to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided. The UV infection control devices market forecast is studied from 2019 to 2026.
- Quantitative analysis of the industry from 2018 to 2026 is presented to enable stakeholders to capitalize on prevailing UV infection control devices market opportunities.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
UV Infection Control Devices Market Report Highlights
| Aspects | Details |
 By Type |
|
 By End User |
|
 By Region |
|
 Key Market Players | UVC Cleaning Systems, Seal Shield, LLC, Lumalier Corp, STERIS plc., THE CLOROX COMPANY, PDI, Inc., XENEX, American Air & Water, Inc., American Ultraviolet, Nikkiso Co., Ltd. |
Analyst Review
UV infection control devices are used to prevent infection in the healthcare settings including hospitals, emergency departments, clinics, ambulatory surgical center, and others. The adoption of UV infection control devices is expected to increase due to rise in the medical procedures, high demand of infection control system, and surge in demand of cost-effective medical devices.
Upsurge in cases of chronic diseases and increase in the surgical procedure helps to increase the demand of infection control devices in the operating rooms. Moreover, increase in government focus on infection control programs and increase in the prevalence of hospital acquired infections (HAI) fuel the growth of the market. In addition, rise in adoption of technologically advanced UV equipment further supplement the growth of the market.
The total market value of UV infection control devices market is $317.42 million in 2018.
The forcast period for UV infection control devices market is 2019 to 2026
The market value of UV infection control devices market in 2019 is $337.29 million.
The base year is 2018 in UV infection control devices market
Top companies such as, Nikkiso Co., Ltd., STERIS plc., The Clorox Company, American Ultraviolet, and UVC Cleaning Systems held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
Mobile type segment is the most influencing segment owing to surge in the prevalence of hospital acquired infections across the globe which lead to surge in the need of these devices.
The major factor that fuels the growth of the global UV infection control devices market includes increase in government focus on infection control programs across the world which led to surge in awareness towards the use of UV infection control devices.
Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 9.1%. This is due to improvements in health standards, surge in disposable incomes, and advancements in technology for the development of new UV infection control devices.
UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others.
UV infection control devices are used to kill infection causing organisms such as bacteria, virus and others
Loading Table Of Content...
